An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms

Veterinary Pathology

Volumn 40, Issue 5, 2003, Pages 496-500

  Beam, S L ^a   Rassnick, K M ^a   Moore, A S ^b   McDonough, S P ^a  

^a Department of Obstetrics Gynecology   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cancer; Cats; Immunohistochemistry; Squamous cell carcinoma; Transitional cell carcinoma

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; VACCINE; ISOENZYME; PROSTAGLANDIN SYNTHASE;

ADENOCARCINOMA; ANIMAL TISSUE; ARTICLE; CARCINOMA; CAT; CONTROLLED STUDY; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; SARCOMA; SQUAMOUS CELL CARCINOMA; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; CAT DISEASE; ENZYMOLOGY; NEOPLASM; PATHOLOGY; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

ANIMALIA; ARMORACIA RUSTICANA; FELIDAE; FELIS CATUS;

ADENOCARCINOMA; ANIMALS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CAT DISEASES; CATS; CYCLOOXYGENASE 2; IMMUNOHISTOCHEMISTRY; ISOENZYMES; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RETROSPECTIVE STUDIES;

EID: 0642344639     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.40-5-496     Document Type: Article

References (22)

1. Arico S, Pattingre S, Bauvy C, et al.: Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem 277:27613-27621, 2002
2. Badaw AF, Badr MZ: Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-γ (review). Int J Oncol 20:1109-1122, 2002
3. Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Mitchell JA: Prostaglandins and the regulation of tumor growth. J Environ Pathol Toxicol Oncol 21:93-101, 2002
4. Boutemmine D, Bouchard N, Boerboom D, et al.: Molecular characterization of canine prostaglandin G/H synthase-2 and regulation in prostatic adenocarcinoma cells in vitro. Endocrinology 143:1134-1143, 2002
5. Brideau C, Van Staden C, Chan CC: In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Am J Vet Res 62:1755-1760, 2001
6. Cohen C, Unger ER, Sgoutias D, Bradley N, Chenggis M: Automated immunohistochemical estrogen receptor in fixed embedded breast carcinomas. Am J Clin Pathol 95:335-339, 1991
7. Dempke W, Rie C, Grothey A, et al.: Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol 127:411-417, 2001
8. Khan KNM, Knapp DW, Denicola DB, Harris RK: Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am J Vet Res 61: 478-481, 2000
9. Khan KNM, Stanfield KM, Trajkovic D, Knapp DW: Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet Pathol 38:116-119, 2001
10. Knapp DW, Richardson RC, Chan TC, et al.: Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Int Med 8:273-278, 1994
11. Kundu N, Fulton AM: Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 62:2343-2346, 2002
12. McEntee MF, Cates JM, Neilsen N: Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 39:428-436, 2002
13. Mohammed SI, Bennett PF, Craig BA, et al.: Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res 62:356-358, 2002
14. 2 concentrations in naturally occurring canine cancer. Prostaglandins Leukot Essent Fatty Acid 64:1-4, 2001
15. Pestili de Almeida EM, Piche C, Sirois J, Dore M: Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J Histochem Cytochem 49:867-875, 2001
16. Ramos-Vara JA, Beissenherz ME: Optimization of immunohistochemical methods using two different antigen retrieval methods on formalin-fixed, paraffin-embedded tissues: experience with 63 markers. J Vet Diagn Invest 12:307-311, 2000
17. Schmidt BR, Glickman NW, DeNicola DB, de Gortari AE, Knapp DW: Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 218:1783-1786, 2001
18. Shaheen NJ, Straus WL, Sandler RS: Chemoprevention of gastrointestinal malignancies with nonsteroidal anti-inflammatory drugs. Cancer 94:950-963, 2002
19. Slamon DJ, Godolphin W, Jones LA, et al.: Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989
20. Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266, 2002
21. Tremblay C, Dore M, Bochsler PN, Sirois J: Induction of prostaglandin G/ H synthetase-2 in a canine model of spontaneous prostatic adenocarcinoma. J Natl Cancer Inst 91:1398-1403, 1999
22. Waskewich C, Blumenthal RD, Li H, Stein R, Goldberg DM, Burton J: Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2 negative hematopoietic and epithelial cell lines. Cancer Res 62:2029-2033, 2002